[HTML][HTML] Circulating miR-25-3p and miR-451a may be potential biomarkers for the diagnosis of papillary thyroid carcinoma

M Li, Q Song, H Li, Y Lou, L Wang - PloS one, 2015 - journals.plos.org
Objective There is no effective and reliable biomarker to distinguish benign thyroid nodules
from papillary thyroid carcinomas (PTC). This study aimed at examining the levels of plasma …

[引用][C] Circulating miRNAs Expression Changes Relevance in Diagnosis and Prognosis of Papillary Thyroid Carcinoma

S Sperber - 2023

[HTML][HTML] The diagnostic and prognostic role of miR-146b-5p in differentiated thyroid carcinomas

C Ferraz, GB Cunha, MMB de Oliveira… - Frontiers in …, 2024 - frontiersin.org
Introduction Samples classified as indeterminate correspond to 10-20% of cytologies
obtained by fine needle biopsy of thyroid nodules, preventing an adequate distinction …

[HTML][HTML] MicroRNA Expression Profiling—Potential Molecular Discrimination of Papillary Thyroid Carcinoma Subtypes

H Silaghi, LA Pop, CE Georgescu, D Muntean… - Biomedicines, 2024 - mdpi.com
Recent research has revealed the importance of miRNAs in the diagnosis and clinical
evolution of papillary thyroid cancer (PTC). We aim to identify a specific miRNA profile that …

[HTML][HTML] Diagnostic Significance of FNAB miRNA Expression in Papillary Thyroid Carcinoma

R Laukienė, L Ambrozaityte, L Cimbalistienė, A Utkus… - Diagnostics, 2022 - mdpi.com
The aim of the study was to evaluate the diagnostic utility of specific miRNAs in the
preoperative assessment of thyroid nodules. One hundred and sixty thyroid fine needle …

BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases

M Zarkesh, A Zadeh-Vakili, M Akbarzadeh, Z Nozhat… - Life sciences, 2019 - Elsevier
Aims Mutations of BRAF oncogene are considered to contribute in the invasiveness and
poor clinicopathologic features of papillary thyroid cancer (PTC). As a step towards …

Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features

I Jahanbani, A Al-Abdallah, RH Ali, N Al-Brahim… - Thyroid, 2018 - liebertpub.com
Background: Papillary thyroid carcinoma (PTC) variants have several overlapping clinical
and pathological features. The World Health Organization recently published a new …

[HTML][HTML] MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer

L Dai, Y Wang, L Chen, J Zheng, J Li, X Wu - World journal of surgical …, 2017 - Springer
Background Many studies have reported several transcriptionally deregulated microRNAs
(miRNAs) in papillary thyroid cancer (PTC) tissue in comparison with benign thyroid nodules …

[HTML][HTML] Evaluating pre-and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules

M Rezaei, AM Khamaneh, N Zarghami, A Vosoughi… - BMC cancer, 2019 - Springer
Background Thyroid cancer is the most common endocrinology cancer that its incidence has
increased in recent decades. miRNAs are new biomarkers in recent studies in the diagnosis …

[HTML][HTML] miR-222 expression is correlated with the ATA risk stratifications in papillary thyroid carcinomas∗

D Xiang, B Tian, T Yang, Z Li - Medicine, 2019 - journals.lww.com
Background: miR-222 is one of the most consistently overexpressed miRNAs in papillary
thyroid carcinoma (PTC). Previous studies demonstrated that miR-222 overexpression …